The Artificial Cartilage Implant market size was xxx million USD with a CAGR xx % from 2015- 2019. It will stretch to xxx million USD in 2020 with a CAGR of xx % from 2020 to 2025.
Cartilage is the semi-rigid specialized connective tissue performing a range of functions in the human body. It is designed to give support, bear weight and withstand tension, torsion, and bending. Cartilage can be classified as articular cartilage, elastic cartilage or fibrocartilage. Each cartilage type has its function e.g. elastic cartilage help in the maintenance of shape and structure of the ear and trachea. Cartilage also acts as a binder between two bones, permitting smooth motion between adjoining bony segments. Articular cartilage is found in synovial joints such as hip, knee, and elbow and is concerned with the mechanical and functional behavior. Osteoarthrosis is the one of the leading disability in the United States. About 80% of people over the age of 65+ in the United States are suffering from osteoarthrosis. Most commonly, distal interphalangeal, first carpometacarpal, and knee joints are affected leading to physical disability.
Artificial cartilage implant market revenue is growing with a significant rate, this is attributed to increasing usage of these implants to repair degenerative cartilages. In addition to this, the artificial cartilage implants are useful in delaying total and partial joint replacement surgeries in elderly. Growing healthcare expenditure and increasing awareness regarding artificial cartilage implants is expected to boost the revenue growth of artificial cartilage implant market. Increasing number of new product launches also drives the market for artificial cartilage implants. However higher pricing of cartilage replacement surgeries along with the risk factors associated with artificial cartilages is expected to hamper the growth of the artificial cartilage implant market over the forecast period.
As the report focuses on global Artificial Cartilage Implant market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
In global market, the following companies are covered:
Biomet
Azellon Cell Therapeutics
Anika Therapeutics
Johnson & Johnson
CellGenix
Medtronic
Stryker Corporation
Smith & Nephew
Market Segment by Product Type
Upper Extremity Joints
Lower Extremity Joints
Vertebral Joints
Market Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Artificial Cartilage Implant market for the forecast period 2020 - 2025?
• What are the driving forces in the Artificial Cartilage Implant market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Artificial Cartilage Implant industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?